Chronic Lymphocytic Leukemia Immunotherapy
Research on chronic lymphocytic leukemia immunotherapy discussed by scientists at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Published in Blood Weekly, June 7th, 2007
New research, "Management of symptomatic, untreated chronic lymphocytic leukemia," is the subject of a report. According to recent research from the United States, "Fludarabine-based regimens have become an increasingly popular first-line approach for symptomatic patients with chronic lymphocytic leukemia. Compared with chlorambucil, fludarabine alone or in combination with cyclophosphamide or rituximab yields higher response rates, higher complete remission rates, and more durable progression-free survival."
"Immunotherapy and chemoimmunotherapy also have the potential to increase the depth of remission as assessed by flow cytometry or molecular techniques. An overall...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-06-07)
More Articles from Blood Weekly
- Artificial Organs
HepaLife Announces Appointment of Senior Medical Device and Healthcare Executive to the Board of Directors - Artificial Organs
Renowned Biomedical Scientists Come to Tucson to Review the World's First and Only temporary Total Artificial Heart - Coagulation
Talecris Initiates Clinical Development Program Evaluating Plasmin for Dissolving Blood Clots and Restoring Blood Flow in Legs - Heart Attack
First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack - Myeloma
Multiple Myeloma Research Foundation (MMRF) 5th Annual Chicago Awards Dinner Raises $700,000.00 to Accelerate a Cure for Blood Cancer - Myeloma
The International Myeloma Foundation Reports New Drug Combination - Velcade Plus Doxil - Approved for Myeloma - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
